|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 145.00 GBX | -2.36% |
|
+1.75% | +13.28% |
| 06-02 | Diaceutics PLC, 2025 Earnings Call, May 26, 2026 | |
| 05-26 | Diaceutics PLC Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | 3.06x | - | 2.51x | 11.4x | 36.88x | -.--% | 167M | |
| -174.71x | 11.6x | 0.6x | 25.63x | 61.56x | -108.99x | -.--% | 72.62B | |
| 39.65x | 4.32x | 0.52x | 3.03x | 24.04x | 38.6x | 1.11% | 4.42B | |
| 116.71x | 6.8x | 2.31x | 16.7x | 24.01x | 146.04x | 0.25% | 3.54B | |
| 37.04x | 13.43x | 2.38x | 11.6x | 25.14x | 28.86x | 1.82% | 2.15B | |
| -26.36x | 3.81x | 0.46x | - | - | - | 0.1% | 1.29B | |
| 41.74x | 8.45x | 1.31x | 17.22x | 26.73x | 29.33x | 0.55% | 1.22B | |
| 15.53x | 4.58x | 0.39x | - | - | - | 0.37% | 1.16B | |
| 24.42x | 2.12x | 31.36x | 3.83x | 13.77x | 17.01x | 0.67% | 1.11B | |
| -1.79x | - | 0.23x | 5.07x | 8.28x | 95.73x | -.--% | 485M | |
| 27.46x | 3.24x | 3.03x | 2.82x | 8.6x | 14.13x | - | 166M | |
| -56.94x | 4.64x | 0.64x | 1.54x | 11.89x | -39.03x | - | 126M | |
| 26.11x | 5.88x | -1.36x | 1.04x | 12.12x | 15.56x | -.--% | 71.5M | |
| Average | 5.74x | 5.99x | 3.49x | 8.27x | 20.69x | 24.92x | 0.44% | 6.81B | |
| Weighted average by Cap. | -135.34x | 10.67x | 1.10x | 23.09x | 55.46x | -82.02x | 0.13% |
- Stock Market
- Stocks
- DXRX Stock
- Sector Diaceutics PLC
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
